ArticleCureus2025
Comparative Analysis of Clinical and Metabolic Profiles in Ischemic Versus Hemorrhagic Stroke Among Adults Presenting to a Tertiary Care Hospital.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Serum Klotho as a potential biomarker for prognosis in acute ischemic stroke.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
AIM AND
backgroundStroke remains a major cause of mortality and morbidity, with substantial heterogeneity in risk factors and outcomes by subtype. This study aimed to compare the prevalence and clinical profiles of ischemic and hemorrhagic strokes and to evaluate the distribution of demographic, neurological, clinical, and metabolic variables among adults presenting within 24 hours of symptom onset. MATERIALS AND
methodsA cross-sectional observational study was conducted at a tertiary care hospital in Lahore from June 2023 to July 2024. A total of 800 adults diagnosed with ischemic or hemorrhagic stroke were enrolled using non-probability consecutive sampling. Demographic, clinical, and laboratory parameters, including body mass index (BMI), Glasgow Coma Scale (GCS), blood pressure, lipid profile, glycated hemoglobin (HbA1c), and renal function, were recorded within 24 hours of admission. Results: In this study of 800 patients, ischemic stroke was identified in 565 (70.6%) and hemorrhagic stroke in 235 (29.4%). Patients aged 50 years or younger had significantly lower odds of ischemic stroke compared to those above 50 years (OR = 0.515, p < 0.001). No significant association was observed between gender and stroke type. High socioeconomic status was associated with a greater proportion of hemorrhagic stroke (χ² = 19.69, p < 0.001). Ever smokers had higher odds of ischemic stroke (OR = 1.405, 95% CI: 1.027-1.921, p = 0.033). Hypertension (HTN) was significantly more frequent in hemorrhagic stroke (OR = 1.453, 95% CI: 1.055-2.000, p = 0.022), while diabetes mellitus (DM) and dyslipidemia showed no significant association with stroke type. Chronic kidney disease was not significantly associated with hemorrhagic stroke (OR = 1.678, 95% CI: 0.996-2.826, p = 0.050). Presentation within 4.5 hours of symptom onset was significantly associated with hemorrhagic stroke (OR = 2.993, 95% CI: 2.034-4.405, p < 0.001). Systolic blood pressure (SBP) and diastolic blood pressure (DBP) were significantly higher in hemorrhagic stroke (SBP mean difference (MD) = -31.30, 95% CI: -36.02 to -26.58, p < 0.001; DBP MD = -10.01, 95% CI: -14.74 to -5.28, p < 0.001). Ischemic stroke patients had higher total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while hemorrhagic stroke patients had higher high-density lipoprotein cholesterol (HDL-C) and blood urea. In-hospital mortality occurred in 74 (13.1%) of the ischemic stroke group and 57 (24.3%) of the hemorrhagic stroke group, with significantly higher mortality associated with hemorrhagic stroke (OR = 2.17, 95% CI: 1.47-3.20, p < 0.001). Mortality was also associated with advanced age, lower Glasgow Coma Scale score, higher systolic blood pressure, and elevated cholesterol and triglyceride levels.
conclusionThis study highlights distinct demographic, clinical, and metabolic profiles between ischemic and hemorrhagic stroke. Hypertension, high socioeconomic status, and early hospital presentation were associated with hemorrhagic stroke, while ischemic stroke was more prevalent among older patients and smokers. In-hospital mortality was significantly higher in hemorrhagic stroke and was linked to advanced age, reduced Glasgow Coma Scale score, and adverse metabolic parameters.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.